{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:10:06Z","timestamp":1778760606874,"version":"3.51.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1777-7","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T06:50:59Z","timestamp":1544770259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2606-995X","authenticated-orcid":false,"given":"Shin-ya","family":"Kawashiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Origuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoichi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohisa","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumori","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"1777_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539\u201351.","journal-title":"N Engl J Med."},{"key":"1777_CR2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732\u20138.","journal-title":"N Engl J Med."},{"key":"1777_CR3","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982\u20134.","journal-title":"J Gastroenterol."},{"key":"1777_CR4","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460\u201371.","journal-title":"Lancet"},{"key":"1777_CR5","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, Pillai S, et al. IgG4-related disease: Clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466\u201375.","journal-title":"Arthritis Rheumatol."},{"key":"1777_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.berh.2012.07.001","volume":"26","author":"M Guma","year":"2012","unstructured":"Guma M, Firestein GS. IgG4-related diseases. Best Pract Res Clin Rheumatol. 2012;26:425\u201338.","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"1777_CR7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.5414\/CNP73385","volume":"73","author":"H Nakashima","year":"2010","unstructured":"Nakashima H, Miyake K, Moriyama M, Tanaka A, Watanabe M, Abe Y, et al. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol. 2010;73:385\u201391.","journal-title":"Clin Nephrol."},{"key":"1777_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.3109\/00016489.2013.831187","volume":"133","author":"N Ohta","year":"2013","unstructured":"Ohta N, Kurakami K, Ishida A, Furukawa T, Suzuki Y, Aoyagi M, et al. Roles of TGF-beta and periostin in fibrosclerosis in patients with IgG4-related diseases. Acta Otolaryngol. 2013;133:1322\u20137.","journal-title":"Acta Otolaryngol."},{"key":"1777_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/art.33320","volume":"64","author":"A Tanaka","year":"2012","unstructured":"Tanaka A, Moriyama M, Nakashima H, Miyake K, Hayashida JN, Maehara T, et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 2012;64:254\u201363.","journal-title":"Arthritis Rheum."},{"key":"1777_CR10","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar3924","volume":"14","author":"H Tsuboi","year":"2012","unstructured":"Tsuboi H, Matsuo N, Iizuka M, Tsuzuki S, Kondo Y, Tanaka A, et al. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res Ther. 2012;14:R171.","journal-title":"Arthritis Res Ther."},{"key":"1777_CR11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/annrheumdis-2017-212110","volume":"77","author":"M Akiyama","year":"2018","unstructured":"Akiyama M, Yasuoka H, Yoshimoto K, Takeuchi T. CC-chemokine ligand 18 is a useful biomarker associated with disease activity in IgG4-related disease. Ann Rheum Dis. 2018;77:1386\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1777_CR12","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1136\/gut.2009.203166","volume":"59","author":"J Parkes","year":"2010","unstructured":"Parkes J, Roderick P, Harris S, Day C, Mutimer D, Collier J, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut. 2010;59:1245\u201351.","journal-title":"Gut"},{"key":"1777_CR13","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","volume":"74","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Feeney E, Deshpande V, Mattoo H, Mahajan V, Kulikova M, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236\u201343.","journal-title":"Ann Rheum Dis."},{"key":"1777_CR14","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/annrheumdis-2012-202843","volume":"73","author":"G Abignano","year":"2014","unstructured":"Abignano G, Cuomo G, Buch MH, Rosenberg WM, Valentini G, Emery P, et al. The enhanced liver fibrosis test: A clinical grade, validated serum test, biomarker of overall fibrosis in systemic sclerosis. Ann Rheum Dis. 2014;73:420\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1777_CR15","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/art.38241","volume":"66","author":"S Lambrecht","year":"2014","unstructured":"Lambrecht S, Smith V, De Wilde K, Coudenys J, Decuman S, Deforce D, et al. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development. Arthritis Rheumatol. 2014;66:418\u201327.","journal-title":"Arthritis Rheumatol."},{"key":"1777_CR16","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3109\/s10165-011-0568-7","volume":"22","author":"K Yanaba","year":"2012","unstructured":"Yanaba K, Asano Y, Tada Y, Sugaya M, Kadono T, Sato S. Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: Association with disease severity. Mod Rheumatol. 2012;22:668\u201375.","journal-title":"Mod Rheumatol."},{"key":"1777_CR17","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/art.40171","volume":"69","author":"M Wu","year":"2017","unstructured":"Wu M, Baron M, Pedroza C, Salazar GA, Ying J, Charles J, et al. CCL2 in the circulation predicts long-term progression of interstitial lung disease in patients with early systemic sclerosis: Data from two independent cohorts. Arthritis Rheumatol. 2017;69:1871\u20138.","journal-title":"Arthritis Rheumatol."},{"issue":"Suppl 100","key":"1777_CR18","first-page":"110","volume":"34","author":"Y Yal\u00e7inkaya","year":"2016","unstructured":"Yal\u00e7inkaya Y, \u00c7inar S, Artim-Esen B, Kamali S, \u00d6cal L, Deniz G, et al. The relationship between vascular biomarkers and disease characteristics in systemic sclerosis: Elevated MCP-1 is predominantly associated with fibrotic manifestations. Clin Exp Rheumatol. 2016;34(Suppl 100):110\u20134.","journal-title":"Clin Exp Rheumatol."},{"key":"1777_CR19","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A. 1997;94:11514\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1777_CR20","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1084\/jem.20100370","volume":"208","author":"SC Jager de","year":"2011","unstructured":"de Jager SC, Berm\u00fadez B, Bot I, Koenen RR, Bot M, Kavelaars A, et al. Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. J Exp Med. 2011;208:217\u201325.","journal-title":"J Exp Med."},{"key":"1777_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol."},{"key":"1777_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/14397595.2017.1290911","volume":"27","author":"H Umehara","year":"2017","unstructured":"Umehara H, Okazaki K, Nakamura T, Satoh-Nakamura T, Nakajima A, Kawano M, et al. Current approach to the diagnosis of IgG4-related disease \u2013 Combination of comprehensive diagnostic and organ-specific criteria. Mod Rheumatol. 2017;27:381\u201391.","journal-title":"Mod Rheumatol."},{"key":"1777_CR23","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","volume":"40","author":"T Shimosegawa","year":"2011","unstructured":"Shimosegawa T, Chari ST, Frulloni L, Kamisawa T, Kawa S, Mino-Kenudson M, et al. International Association of Pancreatology. International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology. Pancreas. 2011;40:352\u20138.","journal-title":"Pancreas"},{"key":"1777_CR24","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","volume":"19","author":"H Ohara","year":"2012","unstructured":"Ohara H, Okazaki K, Tsubouchi H, Inui K, Kawa S, Kamisawa T, et al. Research Committee of IgG4-related Diseases; Research Committee of Intractable Diseases of Liver and Biliary Tract; Ministry of Health, Labor and Welfare, Japan; Japan Biliary Association. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J Hepatobiliary Pancreat Sci. 2012;19:536\u201342.","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"1777_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","volume":"15","author":"M Kawano","year":"2011","unstructured":"Kawano M, Saeki T, Nakashima H, Nishi S, Yamaguchi Y, Hisano S, et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol. 2011;15:615\u201326.","journal-title":"Clin Exp Nephrol."},{"key":"1777_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10384-014-0352-2","volume":"59","author":"H Goto","year":"2015","unstructured":"Goto H, Takahira M, Azumi A, Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1\u20137.","journal-title":"Jpn J Ophthalmol"},{"key":"1777_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.resinv.2015.09.002","volume":"54","author":"S Matsui","year":"2016","unstructured":"Matsui S, Yamamoto H, Minamoto S, Waseda Y, Mishima M, Kubo K. Proposed diagnostic criteria for IgG4-related respiratory disease. Respir Investig. 2016;54:130\u20132.","journal-title":"Respir Investig."},{"key":"1777_CR28","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3899\/jrheum.091153","volume":"37","author":"Y Masaki","year":"2010","unstructured":"Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: Diagnostic in- sights. J Rheumatol. 2010;37:1380\u20135.","journal-title":"J Rheumatol."},{"key":"1777_CR29","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jhep.2013.03.016","volume":"59","author":"R Lichtinghagen","year":"2013","unstructured":"Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ. The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values. J Hepatol. 2013;59:236\u201342.","journal-title":"J Hepatol."},{"key":"1777_CR30","doi-asserted-by":"publisher","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, Khosroshahi A. Development of an IgG4-RD Responder Index. Int J Rheumatol. 2012;2012:259408.","journal-title":"Int J Rheumatol."},{"key":"1777_CR31","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.4049\/jimmunol.1302821","volume":"192","author":"E Sierra-Filardi","year":"2014","unstructured":"Sierra-Filardi E, Nieto C, Dom\u00ednguez-Soto A, Barroso R, S\u00e1nchez-Mateos P, Puig-Kroger A, et al. CCL2 shapes macrophage polarization by GM-CSF and M-CSF: Identification of CCL2\/CCR2-dependent gene expression profile. J Immunol. 2014;192:3858\u201367.","journal-title":"J Immunol."},{"key":"1777_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","volume":"156","author":"S Furukawa","year":"2015","unstructured":"Furukawa S, Moriyama M, Tanaka A, Maehara T, Tsuboi H, Iizuka M, et al. Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Clin Immunol. 2015;156:9\u201318.","journal-title":"Clin Immunol."},{"key":"1777_CR33","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39209","volume":"67","author":"M Akiyama","year":"2015","unstructured":"Akiyama M, Suzuki K, Yamaoka K, Yasuoka H, Takeshita M, Kaneko Y, et al. Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease. Arthritis Rheumatol. 2015;67:2476\u201381.","journal-title":"Arthritis Rheumatol."},{"key":"1777_CR34","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/rheumatology\/kex455","volume":"57","author":"S Kubo","year":"2018","unstructured":"Kubo S, Nakayamada S, Zhao J, Yoshikawa M, Miyazaki Y, Nawata A, et al. Correlation of T follicular helper cells and plasmablasts with the development of organ involvement in patients with IgG4-related disease. Rheumatology (Oxford). 2018;57:514\u201324.","journal-title":"Rheumatology (Oxford)"},{"key":"1777_CR35","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13075-016-1064-4","volume":"18","author":"M Akiyama","year":"2016","unstructured":"Akiyama M, Yasuoka H, Yamaoka K, Suzuki K, Kaneko Y, Kondo H, et al. Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Res Ther. 2016;18:167.","journal-title":"Arthritis Res Ther."},{"key":"1777_CR36","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T, Deshpande V, Della-Torre E, Wallace ZS, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016;138:825\u201338.","journal-title":"J Allergy Clin Immunol."}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1777-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1777-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1777-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T19:10:25Z","timestamp":1576264225000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1777-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1777"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1777-7","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"30 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Ethical approval for the study was given by the institutional review board (reference number 14,102,787) of Nagasaki University Hospital. All patients provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"277"}}